Acute or destabilized heart failure (DHF) is characterized by new or worsening signs and symptoms of heart failure leading to admission to an emergency department. Biomarkers may support the diagnosis, the prognosis and the management of DHF patients. The aim of this review article is to discuss and evaluate the clinical usefulness of both recognized and potential new biomarker tests for use in heart failure.
Gruson, D., Thys, F., & Verschuren, F. (2011). Diagnosing destabilized heart failure in the emergency setting : current and future biomarker tests. Molecular Diagnosis and Therapy, 15(6), 327-340. https://doi.org/10.2165/11595020 (Original work published 2011)